Iron and immunity: a double‐edged sword
- 7 March 2002
- journal article
- review article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 32 (s1) , 70-78
- https://doi.org/10.1046/j.1365-2362.2002.0320s1070.x
Abstract
Iron is a crucial element for many central metabolic pathways of the body. Lack of iron leads to growth arrest and anaemia while increased accumulation of this metal, as it occurs in highly frequent inherited diseases such as hereditary haemochromatosis and thalassaemia, is associated with toxic radical formation and progressive tissue damage. As shown by several groups, iron also modulates immune effector mechanisms, such as cytokine activities (IFN-γ effector pathways towards macrophages), nitric oxide (NO) formation or immune cell proliferation, and thus host immune surveillance. Therefore, gaining control over iron homeostasis is one of the central battlefields in deciding the fate of an infection with intracellular pathogens or a malignant disease. Thus, the reticulo-endothelial system has evoked sophisticated strategies to control iron metabolism in general and especially the handling of the metal within immune cells.Keywords
This publication has 104 references indexed in Scilit:
- Haemochromatosis in the new milleniumJournal of Hepatology, 2000
- The ferritins: molecular properties, iron storage function and cellular regulationPublished by Elsevier ,1999
- The Th1/Th2 paradigmImmunology Today, 1997
- NITRIC OXIDE AND MACROPHAGE FUNCTIONAnnual Review of Immunology, 1997
- Modulatory Potential of Iron Chelation Therapy on Nitric Oxide Formation in Cerebral MalariaThe Journal of Infectious Diseases, 1997
- Linkage of cell-mediated immunity to iron metabolismImmunology Today, 1995
- Lactoferrin: a multifunctional immunoregulatory protein?Immunology Today, 1995
- The antimalarial effect of iron chelators: Studies in animal models and in humans with mild falciparum malariaJournal of Inorganic Biochemistry, 1992
- Body Iron Stores and the Risk of CancerNew England Journal of Medicine, 1988
- Survival and Causes of Death in Cirrhotic and in Noncirrhotic Patients with Primary HemochromatosisNew England Journal of Medicine, 1985